Novozymes A/S, Novonesis (NVZMF.PK,NSIS_B.CO,NSIS-B.CO,NVZMF,NSIS-B), a biotechnology company, on Wednesday announced an agreement to acquire a production facility in Rayong, Thailand from Meihua for around $50 million.
The acquisition aims to expand the company's footprint in Southeast Asia and strengthen its global production capabilities.
The facility includes advanced fermentation capabilities and can be further expanded to support growth, including production of human milk oligosaccharides.
The company plans additional investments in the site and expects it to become commercially operational in 2027.
The move supports Novonesis' long-term GROW strategy, with emerging markets accounting for about one-third of its sales and expected to grow faster than developed markets.
Novonesis is currently trading 0.35% lesser at DKK 395 on the Copenhagen Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.